Buy Crypto
Markets
Spot
FuturesBTC
Earn
Event Center
Rewards Hub
More
100%+ PoR
AVXL

Anavex Life Sciences (AVXL)

NASDAQ
$0.72
-$0.01
(-2.01%)
Previous Close: ⁦$0.74⁩
Market Closed

Last updated: ⁦2026-11-19 06:45:40⁩. Prices reflect the latest closing data and will resume updating on the next trading day. Stock price data is sourced from Massive.

Summary

Anavex Life Sciences (AVXL) operates in the BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES) sector and is listed on NASDAQ. The stock is currently priced at $0.72, with a market capitalization of $68.60M and a P/E ratio of --. Over the past 52 weeks, its price has ranged from $0.71 to $5.36. This page covers its latest market performance, valuation, price trends and company information.

Key Market Data

$68.60M

$0.74

$0.81

$0.72

$0.74

1.01M

1.13M

--

$5.36

$0.71

--

2026-06-30

Anavex Life Sciences (AVXL) Latest Closing Stock Price

Anavex Life Sciences (AVXL) last closed at $0.72 as of 2026-11-19 00:52:00, down 2.01% ($0.01) from the previous close of $0.74.

During the latest regular trading session, AVXL traded between $0.72 and $0.81, with a volume of 1.01M shares. The closing price was near the lower end and near the lower end of its 52-week range.

Anavex Life Sciences (AVXL) 7-Day Stock Price Change

Over the past seven days, Anavex Life Sciences (AVXL) moved from $1.13 to $0.72, representing a decline of 36.02% ($0.41).

The stock traded between $0.71 and $1.23 during the period. The latest price is near the lower end of the 7-day range, indicating strong downward.

The average daily volume was 1.44 million shares, up versus the previous seven-day period, indicating higher trading activity.

AVXL 52-Week Price Position

Position in Range: 0.3%

52W Low$0.71
52W High$5.36

AVXL is currently trading at $0.72, placing it 0.3% of the way from its 52-week low of $0.71 to its 52-week high of $5.36. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.

What is Anavex Life Sciences (AVXL)?

Anavex Life Sciences Corp is a clinical stage biopharmaceutical company engaged in the development of differentiated therapeutics by applying precision medicine to central nervous system(CNS) diseases with high unmet need. It analyzes genomic data from clinical trials to identify biomarkers, which are used in the analysis of its clinical trials for the treatment of neurodegenerative and neurodevelopmental diseases. The company focuses on developing treatments for Alzheimer's disease, Parkinson's disease, schizophrenia, neurodevelopmental, neurodegenerative, and rare diseases, including Rett syndrome, and other central nervous system (CNS) disorders. Its pipeline includes ANAVEX 2-73 and ANAVEX 3-71 and several other compounds in different stages of clinical and pre-clinical development.

Anavex Life Sciences Information

Industry
BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
Employees
34
Exchange
NASDAQ
Company Website

AVXL News

Latest news related to Anavex Life Sciences and AVXL stock.

  • Massive

    INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Anavex Life Sciences Corp. of Class Action Lawsuit and Upcoming Deadlines – AVXL

    Pomerantz Law Firm has filed class action lawsuits against Anavex Life Sciences Corp. (AVXL) for alleged securities fraud and unlawful business practices. The lawsuit follows the May 2026 termination of CEO Christopher Missling and an August 2026 disclosure of material weaknesses in internal controls. Investors have until November 30, 2026, to join as lead plaintiffs.

    Read Full Article
  • Massive

    Deadline Alert: Anavex Life Sciences Corp. Investors Have Until November 30, 2026 to Seek Lead Plaintiff Role in Securities Fraud Class Action, Glancy Prongay Wolke & Rotter LLP Reminds Investors

    Anavex Life Sciences Corp. investors have until November 30, 2026 to seek lead plaintiff status in a securities fraud class action lawsuit. The complaint alleges the company failed to disclose material adverse facts, including inadequate internal controls and regulatory challenges stemming from misconduct by former CEO Christopher Missling. The stock declined following disclosures in May and August 2026 regarding the CEO's termination and material weaknesses in internal controls.

    Read Full Article
  • Massive

    AVXL DEADLINE: ROSEN, TRUSTED INVESTOR COUNSEL, Encourages Anavex Life Sciences Corp. Investors to Secure Counsel Before Important Deadline in Securities Class Action First Filed by the Firm – AVXL

    Rosen Law Firm reminds investors of Anavex Life Sciences Corp. (NASDAQ: AVXL) who purchased securities between November 26, 2025 and August 28, 2026 of the November 30, 2026 lead plaintiff deadline in an ongoing securities class action. The lawsuit alleges that Anavex made false statements regarding internal controls, understated regulatory challenges related to former CEO Christopher Missling's misconduct, and misrepresented business operations and prospects.

    Read Full Article

Ways to Trade AVXL at MEXC

AVXL MEXC RealStocks

Own real AVXL shares through MEXC's regulated brokerage partner.


Suitable for long-term holding.

  • Own the actual shares
  • Receive dividends and voting rights
  • Buy fractional shares starting at $1

How to Buy Anavex Life Sciences (AVXL) Stock on MEXC

Eligible investors can buy real shares of Anavex Life Sciences (AVXL) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.

Step 1: Open and Verify Your RealStocks Account
Step 1: Open and Verify Your RealStocks Account
Log in to the MEXC App, go to Trade → RealStocks, and select Open Account. Complete the required account-opening and identity verification process with MEXC's partner licensed broker.
Step 2: Transfer USDT to Your RealStocks Account
Step 2: Transfer USDT to Your RealStocks Account
Go to Wallets → RealStocks and transfer USDT from your Spot Account to your RealStocks Account. RealStocks are quoted in USD, while account funding can be completed using USDT.
Step 3: Search for AVXL and Place Your Order
Step 3: Search for AVXL and Place Your Order
Open the RealStocks trading page and search for AVXL. Select a market or limit order, enter the price and quantity as required, review the order details, and submit your order. Once filled, the corresponding real shares will be held in your RealStocks Account.

Frequently Asked Questions (FAQ)

1.What is Anavex Life Sciences (AVXL) stock price today?
Anavex Life Sciences (AVXL) is currently trading at $0.72, down 2.01% ($0.01) from the previous close of $0.74. Intraday prices update in real time during regular trading hours.
2.Is AVXL stock going up or down today?
As of 2026-11-19 00:52:00, AVXL is trading at $0.72, down 2.01% ($0.01) from its previous close of $0.74. The stock has traded between $0.72 and $0.81 during today’s regular session. Past price movements do not guarantee future results.
3.What is AVXL pre-market price?
As of 2026-11-19 00:52:00, AVXL is trading at $0.78 in pre-market trading, up 5.27% ($0.04) from the previous close of $0.74. Pre-market prices reflect trading activity before the regular session opens and may experience lower liquidity and higher volatility.
4.What is AVXL after-hours price?
As of 2026-11-19 00:52:00, AVXL is trading at $0.73 in after-hours trading, up 0.97% ($0.01) from the regular-session close of $0.72. After-hours prices may differ from the regular session’s opening price due to lower liquidity and wider bid-ask spreads.
5.Is AVXL stock trading now?
AVXL trades on the NASDAQ exchange during regular hours, Monday through Friday, 9:30 AM to 4:00 PM ET, excluding public holidays. Pre-market and after-hours trading are also available through select brokers outside these hours.
6.Where does AVXL sit relative to its 52-week high and low?
Over the past 52 weeks, AVXL has traded between a low of $0.71 and a high of $5.36. At $0.72, the stock is positioned 0.3% of the way from its 52-week low to its 52-week high, providing context for its current price within the one-year trading range.
7.What sector is Anavex Life Sciences in?
Anavex Life Sciences (AVXL) operates in the BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES) sector. Sector classification helps investors compare it with companies exposed to similar market trends and competitive conditions.
8.What is Anavex Life Sciences's market capitalization and where is it listed?
Anavex Life Sciences is listed on the NASDAQ exchange with a market capitalization of $68.60M. Market cap reflects the total market value of all outstanding shares and is commonly used to classify stocks by size.
9.How is AVXL valued in terms of P/E ratio and EPS?
AVXL trades at a P/E ratio of --, based on trailing-twelve-month EPS of $-0.14. P/E ratio compares the stock price to earnings per share and is a common starting point for assessing valuation relative to peers.
10.Does Anavex Life Sciences pay a dividend?
Anavex Life Sciences pays an indicated annual cash dividend of $0.00 per share, with a current dividend yield of 0.00% based on the latest share price. Dividend policies are subject to change at the board's discretion.

Explore More US Stocks

Largest Market Cap

See US stocks with the highest market capitalization

Most Actively Traded

Discover today's most actively traded US stocks

Top 5 Cryptocurrencies

Explore the cryptocurrencies with the highest market capitalization

Compliance Disclosure and Data Source

Stock prices and market data on this page, including price changes and market status, are provided by Massive and other third-party news and data platforms. Market data may be delayed and may differ from prices on other platforms or the prices at which trades are executed on MEXC. MEXC does not guarantee the accuracy, completeness, or timeliness of third-party data. MEXC offers trading products related to AVXL, including Stocks, Tokenized Stocks, and Stock Futures.

Disclaimer

The stock price information displayed on this page is provided for reference purposes only and may be delayed or differ from real-time market data. Prices, charts, and related metrics do not constitute investment advice and should not be relied upon for trading or investment decisions. MEXC is not responsible for any losses incurred based on the stock price information provided on this page. Please refer to official market sources or consult licensed financial professionals before making any investment decisions.

Search Stocks

AVXL Stock Calculator

Estimate the value between AVXL shares and USD.

AVXL Shares to USD

AVXL Shares
AVXL
AVXL
USD
USD
USD

1.00 AVXL shares = 0.723 USD

Calculations are estimates based on the latest available price and are for reference only.